Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 20, 2021
As the year draws to a close, the temptation to claim wisdom from adversity and experience becomes irresistible. We did it last year, by exploring what we learnt while the world burned around us. 2021 was perhaps a marginal improvement: not quite the best of times, but not quite the worst of times, ...
Blog Post
December 20, 2021
High-income countries play a key role in the global response to Omicron. Their decisions can help increase global vaccination coverage, curb the spread of current variants, and prevent the emergence of new ones. Here we outline three actions high-income countries should take to help end the pandemic...
Blog Post
December 20, 2021
CGD co-hosted an online event in November with the U4 Anti-Corruption Resource Centre to discuss the progress and challenges in pursuit of a transparent and equitable roll out of COVID-19 vaccine. Following on earlier calls for transparency, this event built on new research from U4 and pointed ...
Blog Post
December 02, 2021
Many countries around the world have punished most of the African continent for the scientific discovery of the Omicron variant through the imposition of travel bans. These travel bans are more injury upon the injury of low vaccination in Africa. Even well-intentioned rallying phrases such as “vacci...
Blog Post
November 12, 2021
Obviously, an ethical vaccine distribution would start with a far more equitable sharing of vaccines between rich and less-rich nations. More pragmatically, the current huge imbalance in the global distribution of shots invites another outbreak of a new variant, against which the US and other high-i...
Blog Post
October 28, 2021
We conducted a joint review of the portfolio management activities of the committee overseeing COVAX R&D and manufacturing investments, known as RDMIC (R&D and Manufacturing Investment Committee). Our aim was to assess learnings from investments to date and suggest ways to strengthen future ...
Blog Post
October 21, 2021
After buying up the World’s vaccine supply to ensure they can protect their own populations, rich countries have found themselves struggling to use the vaccine surpluses they accumulated. One response has been to donate the spare doses to countries who need them more. This is laudable, and countries...
Blog Post
October 21, 2021
Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vac...